CTOs on the Move

Brooks Rehabilitation

www.brooksrehab.org

 
Our foundation supports many programs throughout the Brooks System of Care, including clinical research, adaptive sports and wellness, school re-entry, and free care for those who need it most. Our Volunteer Services department provides an opportunity for personal growth, education, and service to others. Our goal is to meet the needs of our volunteers while carrying out our vision of providing world-class service to our patients. Volunteer assignments are made according to interest, availability, and the skills needed to fulfill task requirements.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Ken Sturtz
 Chief Technology Officer Profile
Ken Sturtz
 Chief Information Officer Profile

Similar Companies

Marlow Manor Assisted Living

Marlow Manor Assisted Living is a Anchorage, AK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Excedrin

Excedrin is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HNI Healthcare

HNI Healthcare designs intelligent processes and technology to empower talented people to transform healthcare.

Allphase Clinical Research Services

Allphase Clinical Research Services Inc. is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.